Infectious Disease PractitionerInvestigational HCV drug combo yields high SVR12 rates in compensated cirrhosisOctober 1, 2016Hepatitis
Infectious Disease PractitionerSimple interventions markedly improve hepatitis careSeptember 28, 2016Hepatitis
Infectious Disease PractitionerNew ELISA better differentiates chronic, acute hepatitis E infectionSeptember 12, 2016Hepatitis
Infectious Disease PractitionerHepatitis B vaccine response suppressed by maternal antibodiesAugust 26, 2016VaccinesPediatricsHepatitis
Infectious Disease PractitionerPatients with HBV inadequately monitored for disease activityAugust 25, 2016Hepatitis
Infectious Disease PractitionerEradication strategies for chronic hepatitis B infectionAugust 24, 2016Hepatitis
Infectious Disease PractitionerYounger age, inconsistency of care affect antiviral adherence in hepatitis BAugust 23, 2016Hepatitis
Infectious Disease PractitionerStudy finds clues to fibrosis progression in chronic HCV infectionAugust 10, 2016Hepatitis
Infectious Disease PractitionerElbasvir-grazoprevir works effectively against HCV despite current drug useAugust 8, 2016Hepatitis
Infectious Disease PractitionerWHO analysis: Cost of new HCV meds unaffordable globallyJuly 30, 2016Hepatitis
Infectious Disease PractitionerHepatitis C infection rates rising in women, young childrenJuly 21, 2016HepatitisPediatrics
Infectious Disease PractitionerHIV patients with elevated ALT at significant risk of chronic liver diseaseJuly 11, 2016HIVHepatitis